- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sphingolipids in cardiovascular diseases and metabolic disorders ; volume:14 ; number:1 ; day:16 ; month:6 ; year:2015 ; pages:1-8 ; date:12.2015
Lipids in health and disease ; 14, Heft 1 (16.6.2015), 1-8, 12.2015
- Urheber
-
Borodzicz, Sonia
Czarzasta, Katarzyna
Kuch, Marek
Cudnoch-Jedrzejewska, Agnieszka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-015-0053-y
- URN
-
urn:nbn:de:101:1-2021080720572926330400
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Borodzicz, Sonia
- Czarzasta, Katarzyna
- Kuch, Marek
- Cudnoch-Jedrzejewska, Agnieszka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inherited disorders, metabolic disorders and rare diseases
Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study
Endocrine-metabolic markers and subclinical cardiovascular disorders
Endocrine-metabolic markers and subclinical cardiovascular disorders
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases
Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Cardiovascular diseases
Cardiovascular diseases
Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases
Inherited disorders, metabolic disorders and rare diseases
Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study
Endocrine-metabolic markers and subclinical cardiovascular disorders
Endocrine-metabolic markers and subclinical cardiovascular disorders
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases
Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Cardiovascular diseases
Cardiovascular diseases
Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases
Inherited disorders, metabolic disorders and rare diseases
Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study
Endocrine-metabolic markers and subclinical cardiovascular disorders
Endocrine-metabolic markers and subclinical cardiovascular disorders
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases
Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
Cardiovascular diseases
Cardiovascular diseases